Essential Partners’s Tango Therapeutics TNGX Stock Holding History

Essential Partners’s Portfolio TNGX Stock Details TNGX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$100	Hold	4	–	–	﹤0.01%	2696
2026 Q2	$125	Hold	4	–	–	﹤0.01%	2720
2026 Q1	$84	Hold	4	–	–	﹤0.01%	2740
2025 Q4	$35	Buy	+4	New	+$34	﹤0.01%	2682

Other funds holding TNGX

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Y-Intercept (HK) Hong Kong $4.52B AUM 6.6% 1-Year Est. Return

Tema ETFs New York $2.69B AUM 42.96% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

FFO

Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Essential Partners's TNGX Position: Q3 2026 in Review

Essential Partners held its Tango Therapeutics (TNGX) position steady in Q3 2026 at 4 shares worth $100. The position accounts for ﹤0.01% of the portfolio, ranked #2696.

Essential Partners first reported a position in TNGX in Q4 2025 and has held it in 4 quarters since. The position peaked at $125 in Q2 2026. 8 funds tracked by Wall St. Rank hold TNGX as of Q3 2026.

Essential Partners held 4 shares of Tango Therapeutics worth $100 as of Q3 2026.
Essential Partners left its Tango Therapeutics share count unchanged in Q3 2026.
Tango Therapeutics made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #2696 holding.
Essential Partners first reported a position in Tango Therapeutics in Q4 2025 and has held it in 4 quarters since.
Essential Partners's Tango Therapeutics position peaked at $125 in Q2 2026.
8 funds tracked by Wall St. Rank held Tango Therapeutics as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.